This content is exclusively provided by FAO / FAOLEX

National Action Plan for Antimicrobial Resistance Containment in Bangladesh 2017-2022.

Country
Type of law
Policy
Source

Abstract
This National Action Plan (NAP) for Antimicrobial Resistance Containment in Bangladesh 2017-2022 is a multisectoral policy document. The NAP was developed based on the national strategy. Objectives of the National Strategy for ARC: 1. To establish multi-sectoral approach for planning, coordination and implementation of antimicrobial resistance containment (ARC) activities; 2. To promote and ensure rational use of antimicrobial agents in human health, livestock and fisheries sectors ; 3. To promote and strengthen infection prevention and control measures to minimize the emergence and spread of AMR; 4. Promoting and strengthening biosafety and biosecurity principles and practices and containment measures; 5. To review, update and strengthening of regulatory provisions; 6. To strengthen surveillance system for AMR containment; 7. To promote operational research and education in the area of AMR; 8. To establish Advocacy, Communication and Social Mobilization (ACSM) for ARC activities.
The National Action Plan consists of actions as follows: 1. Establish multi-sectoral approach for planning, coordination and implementation of ARC 2. Ensure rational use of antimicrobial agents in human health, Livestock, Fisheries sectors and Environment a. Develop/update standard treatment guideline (STG) for human and animal health sector based on AST data and ensure adherence to STG; b. Ensure availability of AMs at all healthcare facilities (HCFs); c. Ensuring quality laboratory testing and reporting of antimicrobial susceptibility test (AST) for right selection of AMs d. Develop Antibiotic policy; e. Establish/ strengthen national reference laboratory and regional Microbiology laboratories; f. Ensure GLP at all Microbiology laboratories; g. Enforce and enhance regulatory provisions for use AMs; h. Ensure good pharmacy practice (GPP) at points of sale of AMs; i. Ensure good manufacturing practice (GMP) at Pharmaceutical industries; j. Enforce and enhance regulatory provisions for use of AMs 3. Promote and strengthen infection prevention and control (IPC) measures in both human and animal health sectors to minimize emergence and spread of AMT 4. Establish AMR-surveillance system; a. Establish national Reference Microbiology Laboratory (RMLs) and select regional microbiology laboratories for AMR- surveillance; b. Web-based laboratory surveillance and laboratory networking for AMR; c. Monitoring of AMs use. 5. Promote basic, experimental and operational research in the area of AMR 6. Establish advocacy, communication and social mobilization (ACSM).
Date of text
Repealed
No
Publication reference
Ministry of Health & Family Welfare.
Source language

English

Legislation Amendment
No